| . | . | Variance explained per component . | |||
|---|---|---|---|---|---|
| Model . | Groups . | 1 . | 2 . | 3 . | 4 . |
| 1 | Lipids (X) | 47.7% | 66.5% | 99.0% | 100% |
| Systolic blood pressure (Y) | 2.0% | 2.7% | 2.7% | 3.2% | |
| 2 | Lipids (X) | 49.1% | 74.0% | 99.3% | 100% |
| Diastolic blood pressure (Y) | 1.4% | 1.5% | 1.6% | 1.7% | |
| 3 | Lipids (X) | 33.4% | 49.7% | 98.8% | 100% |
| Pulse (Y) | 4.2% | 4.6% | 4.6% | 5.0% | |
| 4 | Lipids (X) | 33.7% | 59.2% | 99.4% | 100% |
| Anthropometrics (Y) | 19.4% | 21.2% | 21.4% | 21.5% | |
| 5 | Lipids (X) | 41.4% | 83.6% | 99.3% | 100% |
| Biochemistry (Y) | 12.1% | 12.7% | 12.8% | 12.9% | |
| 6 | Lipids (X) | 42.6% | 84.5% | 93.2% | 100% |
| MRI measurements (Y) | 3.9% | 4.2% | 5.8% | 7.5% | |
| 7 | Lipids (X) | 38.1% | 84.9% | 87.0% | 100% |
| Sex hormones (Y) | 2.9% | 3.0% | 4.4% | 4.6% | |
| . | . | Variance explained per component . | |||
|---|---|---|---|---|---|
| Model . | Groups . | 1 . | 2 . | 3 . | 4 . |
| 1 | Lipids (X) | 47.7% | 66.5% | 99.0% | 100% |
| Systolic blood pressure (Y) | 2.0% | 2.7% | 2.7% | 3.2% | |
| 2 | Lipids (X) | 49.1% | 74.0% | 99.3% | 100% |
| Diastolic blood pressure (Y) | 1.4% | 1.5% | 1.6% | 1.7% | |
| 3 | Lipids (X) | 33.4% | 49.7% | 98.8% | 100% |
| Pulse (Y) | 4.2% | 4.6% | 4.6% | 5.0% | |
| 4 | Lipids (X) | 33.7% | 59.2% | 99.4% | 100% |
| Anthropometrics (Y) | 19.4% | 21.2% | 21.4% | 21.5% | |
| 5 | Lipids (X) | 41.4% | 83.6% | 99.3% | 100% |
| Biochemistry (Y) | 12.1% | 12.7% | 12.8% | 12.9% | |
| 6 | Lipids (X) | 42.6% | 84.5% | 93.2% | 100% |
| MRI measurements (Y) | 3.9% | 4.2% | 5.8% | 7.5% | |
| 7 | Lipids (X) | 38.1% | 84.9% | 87.0% | 100% |
| Sex hormones (Y) | 2.9% | 3.0% | 4.4% | 4.6% | |
Partial least squares analysis, visit 1. Lipids were used as independent variables against each group in turn. All data were ln-transformed.
Abbreviation: MRI, magnetic resonance imaging.
| . | . | Variance explained per component . | |||
|---|---|---|---|---|---|
| Model . | Groups . | 1 . | 2 . | 3 . | 4 . |
| 1 | Lipids (X) | 47.7% | 66.5% | 99.0% | 100% |
| Systolic blood pressure (Y) | 2.0% | 2.7% | 2.7% | 3.2% | |
| 2 | Lipids (X) | 49.1% | 74.0% | 99.3% | 100% |
| Diastolic blood pressure (Y) | 1.4% | 1.5% | 1.6% | 1.7% | |
| 3 | Lipids (X) | 33.4% | 49.7% | 98.8% | 100% |
| Pulse (Y) | 4.2% | 4.6% | 4.6% | 5.0% | |
| 4 | Lipids (X) | 33.7% | 59.2% | 99.4% | 100% |
| Anthropometrics (Y) | 19.4% | 21.2% | 21.4% | 21.5% | |
| 5 | Lipids (X) | 41.4% | 83.6% | 99.3% | 100% |
| Biochemistry (Y) | 12.1% | 12.7% | 12.8% | 12.9% | |
| 6 | Lipids (X) | 42.6% | 84.5% | 93.2% | 100% |
| MRI measurements (Y) | 3.9% | 4.2% | 5.8% | 7.5% | |
| 7 | Lipids (X) | 38.1% | 84.9% | 87.0% | 100% |
| Sex hormones (Y) | 2.9% | 3.0% | 4.4% | 4.6% | |
| . | . | Variance explained per component . | |||
|---|---|---|---|---|---|
| Model . | Groups . | 1 . | 2 . | 3 . | 4 . |
| 1 | Lipids (X) | 47.7% | 66.5% | 99.0% | 100% |
| Systolic blood pressure (Y) | 2.0% | 2.7% | 2.7% | 3.2% | |
| 2 | Lipids (X) | 49.1% | 74.0% | 99.3% | 100% |
| Diastolic blood pressure (Y) | 1.4% | 1.5% | 1.6% | 1.7% | |
| 3 | Lipids (X) | 33.4% | 49.7% | 98.8% | 100% |
| Pulse (Y) | 4.2% | 4.6% | 4.6% | 5.0% | |
| 4 | Lipids (X) | 33.7% | 59.2% | 99.4% | 100% |
| Anthropometrics (Y) | 19.4% | 21.2% | 21.4% | 21.5% | |
| 5 | Lipids (X) | 41.4% | 83.6% | 99.3% | 100% |
| Biochemistry (Y) | 12.1% | 12.7% | 12.8% | 12.9% | |
| 6 | Lipids (X) | 42.6% | 84.5% | 93.2% | 100% |
| MRI measurements (Y) | 3.9% | 4.2% | 5.8% | 7.5% | |
| 7 | Lipids (X) | 38.1% | 84.9% | 87.0% | 100% |
| Sex hormones (Y) | 2.9% | 3.0% | 4.4% | 4.6% | |
Partial least squares analysis, visit 1. Lipids were used as independent variables against each group in turn. All data were ln-transformed.
Abbreviation: MRI, magnetic resonance imaging.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
